Do you want to read an article? Please log in or register.
Technique of retinal gene therapy: delivery of viral vector into the subretinal space
Macular DiseasesRetinal Diseases
Related content
Retinal Diseases
Efficacy and Safety of Retinal Gene Therapy Using Adeno-Associated Virus Vector for Patients With Choroideremia: A Randomized Clinical Trial
JAMA Ophthalmol.
Fischer MD, Ochakovski GA, Beier B, Seitz IP, Vaheb Y, Kortuem C, Reichel FFL, Kuehlewein L, Kahle NA, Peters T, Girach A, Zrenner E, Ueffing M, MacLaren RE, Bartz-Schmidt KU, Wilhelm B
doi: 10.1001/jamaophthalmol.
Retinal Diseases
Structural and Functional Recovery Following Limited Iatrogenic Macular Detachment for Retinal Gene Therapy
JAMA Ophthalmol.
Simunovic MP, Xue K, Jolly JK, MacLaren RE
doi: 10.1001/
RECOMMENDED
Blindness and Vision Impairment
Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia: A Nonrandomized Controlled Trial
★ 2
Recommended by
Prof. Dr emer. Josef Flammer, Faculty Member
doi: 10.1001/jamaophthalmol.2020.1032.
Retinal Diseases
The Role of the Human Visual Cortex in Assessment of the Long-Term Durability of Retinal Gene Therapy in Follow-on RPE65 Clinical Trial Patients
Ophthalmology.
Ashtari M, Nikonova ES, Marshall KA, Young GJ, Aravand P, Pan W, Ying GS, Willett AE, Mahmoudian M, Maguire AM, Bennett J
doi: 10.1016/j.ophtha.2017.01.029.
Retinal Diseases
Cone Spacing Correlates With Retinal Thickness and Microperimetry in Patients With Inherited Retinal Degenerations
Invest Ophthalmol Vis Sci.
Foote KG, De la Huerta I, Gustafson K, Baldwin A, Zayit-Soudry S, Rinella N, Porco TC, Roorda A, Duncan JL
doi: 10.1167/iovs.18-25688.
COMMENTED
Macular Diseases
Development of an inducible anti-VEGF rAAV gene therapy strategy for the treatment of wet AMD
Sci Rep.
Reid CA, Nettesheim ER, Connor TB, Lipinski DM
doi: 10.1038/
Gene therapy in optic nerve disease
Curr Opin Ophthalmol.
DeBusk A, Moster ML
doi: 10.1097/ICU.
Retinal Diseases
Association of Disorganization of Retinal Inner Layers With Visual Acuity Response to Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Secondary to Retinal Vein Occlusion
JAMA Ophthalmol.
Babiuch AS, Han M, Conti FF, Wai K, Silva FQ, Singh RP
doi: 10.1001/jamaophthalmol.
Further Publications
AI-based monitoring of retinal fluid in disease activity and under therapy
Prog Retin Eye Res
Schmidt-Erfurth U, Reiter GS, Riedl S, Seeböck P, Vogl WD, Blodi BA, Domalpally A, Fawzi A, Jia Y, Sarraf D, Bogunovic H
doi: 10.1016/j.preteyeres.2021.100972